Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

Thrombosis and Haemostasis

Volumn 96, Issue 3, 2006, Pages 337-341

  Ruffatti, Amelia ^a   Tonello, Marta ^a   Del Ross, Teresa ^a   Cavazzana, Anna ^a   Grava, Chiara ^a   Noventa, Franco ^a   Tona, Francesco ^a   Iliceto, Sabino ^a   Pengo, Vittorio ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Antiphospholipid antibodies; Pregnancy; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; WARFARIN;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BUDD CHIARI SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; LABORATORY TEST; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; PREDICTION; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; STROKE; THIRD TRIMESTER PREGNANCY; THROMBOEMBOLISM;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RISK FACTORS; THROMBOPHILIA;

EID: 33748597665     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-05-0287     Document Type: Article

References (30)

1. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
3. Detkova D, Gil-Aguado A, Lavilla P, et al. Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome? Lupus 1999; 8: 430-8.
4. Lee EY, Lee CK, Lee TH, et al. Does the antibeta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res 2003; 111: 29-32.
5. Pengo V, Biasiolo A, Pegoraro C, et al. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005; 93: 1147-52.
6. Sailer T, Zoghlami C, Kurz C, et al. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost 2006; 95: 796-801.
7. Zoghlami-Rintelen C, Vormittag I, Sailer T, et al. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost 2005; 3: 1160-5.
8. Khamashta MA. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies. J Autoimmunity 2000; 15: 249-53.
9. Erkan D, Merrill JT, Yazici Y, et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001; 44: 1466-7.
10. Vitali C, Bombardieri VC, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rhemn 1988; 3: 315-24.
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-7, 403-7.
16. Pengo V, Biasiolo A, Pegoraro C, et al. A two-step coagulation test to identify anti-beta2-glycoprotein I lupus anticoagulants. J Thromb Haemost 2004; 2: 702-7.
17. Brandt JT, Triplett DA, Alvin B, et al. Criteria for the diagnosis of lupus anticoagulant. Thromb Haemost 1995; 74: 1185-90.
18. 2-Glycoprotein-I auto- antibodies. Thromb Haemost 1999; 81: 256-8.
19. Biasiolo A, Pengo V Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis. Blood Coagul Fibrinolysis 1993; 4: 425-8.
20. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-8.
21. 2-Glycoprotein-I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
22. 2-Glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.
23. Allison PD. Logistic regression using die SAS system. Theory and Application. SAS institute inc. Cary, NC, USA, 1999; chapter 3.4, pp 39-48.
24. Ruffatti A, Orsini A, DiLenardo L, et al. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid-related fetal loss. Clin Exp Rheumatol 1997; 15: 499-505.
25. Ruffatti A, Favaro M, Tonello M, et al. Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome. Lupus 2005; 14: 120-8.
26. Garcia CO, Kanbour-Shakir A, Tang H, et al. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol 1997; 37: 118-24.
27. Branch DW Scott JR, Kochenour NK, et al. Obstetric complications associated with the Lupus Anticoagulant. N Engl J Med 1985; 313: 1322-6.
28. Branch DW. Antiphospholipid antibodies and foetal compromise. Thromb Res 2004; 114: 415-8.
29. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996; 100: 530-6.
30. Tincani A, Branch W, Levy RA, et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 2003; 12: 524-9.